Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 1
2016 1
2017 2
2018 3
2019 1
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

8 results
Results by year
Filters applied: . Clear all
Page 1
IKKα Kinase Regulates the DNA Damage Response and Drives Chemo-resistance in Cancer.
Colomer C, Margalef P, Villanueva A, Vert A, Pecharroman I, Solé L, González-Farré M, Alonso J, Montagut C, Martinez-Iniesta M, Bertran J, Borràs E, Iglesias M, Sabidó E, Bigas A, Boulton SJ, Espinosa L. Colomer C, et al. Among authors: vert a. Mol Cell. 2019 Aug 22;75(4):669-682.e5. doi: 10.1016/j.molcel.2019.05.036. Epub 2019 Jul 10. Mol Cell. 2019. PMID: 31302002 Free PMC article.
NF-κB Members Left Home: NF-κB-Independent Roles in Cancer.
Colomer C, Marruecos L, Vert A, Bigas A, Espinosa L. Colomer C, et al. Among authors: vert a. Biomedicines. 2017 May 25;5(2):26. doi: 10.3390/biomedicines5020026. Biomedicines. 2017. PMID: 28587092 Free PMC article. Review.
Manic Fringe deficiency imposes Jagged1 addiction to intestinal tumor cells.
López-Arribillaga E, Rodilla V, Colomer C, Vert A, Shelton A, Cheng JH, Yan B, Gonzalez-Perez A, Junttila MR, Iglesias M, Torres F, Albanell J, Villanueva A, Bigas A, Siebel CW, Espinosa L. López-Arribillaga E, et al. Among authors: vert a. Nat Commun. 2018 Jul 31;9(1):2992. doi: 10.1038/s41467-018-05385-0. Nat Commun. 2018. PMID: 30065304 Free PMC article.
IKKα is required in the intestinal epithelial cells for tumour stemness.
Colomer C, Margalef P, Gonzalez J, Vert A, Bigas A, Espinosa L. Colomer C, et al. Among authors: vert a. Br J Cancer. 2018 Mar 20;118(6):839-846. doi: 10.1038/bjc.2017.459. Epub 2018 Feb 13. Br J Cancer. 2018. PMID: 29438366 Free PMC article.
Transcriptional profiling of NCI/ADR-RES cells unveils a complex network of signaling pathways and molecular mechanisms of drug resistance.
Vert A, Castro J, Ribó M, Vilanova M, Benito A. Vert A, et al. Onco Targets Ther. 2018 Jan 4;11:221-237. doi: 10.2147/OTT.S154378. eCollection 2018. Onco Targets Ther. 2018. PMID: 29379303 Free PMC article.
A nuclear-directed human pancreatic ribonuclease (PE5) targets the metabolic phenotype of cancer cells.
Vert A, Castro J, Ribó M, Benito A, Vilanova M. Vert A, et al. Oncotarget. 2016 Apr 5;7(14):18309-24. doi: 10.18632/oncotarget.7579. Oncotarget. 2016. PMID: 26918450 Free PMC article.
Activating transcription factor 3 is crucial for antitumor activity and to strengthen the antiviral properties of Onconase.
Vert A, Castro J, Ribó M, Benito A, Vilanova M. Vert A, et al. Oncotarget. 2017 Feb 14;8(7):11692-11707. doi: 10.18632/oncotarget.14302. Oncotarget. 2017. PMID: 28035074 Free PMC article.
Generation of new cytotoxic human ribonuclease variants directed to the nucleus.
Vert A, Castro J, Ruiz-Martínez S, Tubert P, Escribano D, Ribó M, Vilanova M, Benito A. Vert A, et al. Mol Pharm. 2012 Oct 1;9(10):2894-902. doi: 10.1021/mp300217b. Epub 2012 Sep 20. Mol Pharm. 2012. PMID: 22957849
Feedback